PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsTriamcinolone
Triamcinolone
Aristocort, Kenacort, Kenalog, Mytrex A, Nasacort, Triamcinolone, Triderm, Triesence, Xipere, Zilretta (triamcinolone) is a small molecule pharmaceutical. Triamcinolone was first approved as Aristocort on 1982-01-01. It is used to treat adrenal insufficiency, allergic rhinitis perennial, ankylosing spondylitis, atopic dermatitis, and berylliosis amongst others in the USA. The pharmaceutical is active against glucocorticoid receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
musculoskeletal diseasesD009140
digestive system diseasesD004066
respiratory tract diseasesD012140
otorhinolaryngologic diseasesD010038
nervous system diseasesD009422
eye diseasesD005128
urogenital diseasesD000091642
hemic and lymphatic diseasesD006425
hereditary congenital and neonatal diseases and abnormalitiesD009358
Show 7 more
Trade Name
FDA
EMA
Kenalog, Nasacort, Triamcinolone, Triderm, Triesence, Xipere, Zilretta (discontinued: Allernaze, Aristocort, Aristocort a, Aristogel, Azmacort, Flutex, Kenacort, Kenalog, Nasacort, Oralone, Triacet, Triacort, Triamcinolone, Trianex, Triatex, Trivaris, Trymex)
Combinations
Nystatin triamcinolone (discontinued: Myco-triacet, Mycolog-ii, Mykacet, Mytrex a, Mytrex f, Neomycin sulfate-triamcinolone, Nystatin triamcinolone, Nystatin-triamcinolone)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Triamcinolone diacetate
Tradename
Company
Number
Date
Products
ARISTOCORTAstellas PharmaN-011960 DISCN1982-01-01
1 products
KENACORTDelcor AssetN-012515 DISCN1982-01-01
1 products
ARISTOCORTFosun PharmaceuticalN-011685 DISCN1982-01-01
1 products
ARISTOCORTFosun PharmaceuticalN-012802 DISCN1982-01-01
1 products, RLD
Hide discontinued
Triamcinolone
Tradename
Company
Number
Date
Products
ARISTOCORTAstellas PharmaN-011161 DISCN1982-01-01
5 products
KENACORTDelcor AssetN-011283 DISCN1982-01-01
4 products
Hide discontinued
Triamcinolone acetonide
Tradename
Company
Number
Date
Products
KENALOG-10Bristol Myers SquibbN-012041 RX1982-01-01
1 products, RLD
KENALOG-40Bristol Myers SquibbN-014901 RX1982-01-01
1 products, RLD, RS
KENALOG-80Bristol Myers SquibbN-014901 RX2019-04-12
1 products, RLD, RS
XIPEREBausch Health CompaniesN-211950 RX2021-10-22
1 products, RLD, RS
NASACORT ALLERGY 24 HOURSanofiN-020468 OTC2013-10-11
1 products, RLD, RS
TRIESENCEHarrowN-022048 RX2007-11-29
1 products, RLD, RS
ZILRETTAPacira BioSciencesN-208845 RX2017-10-06
1 products, RLD, RS
Show 9 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
24 hour nasal allergyANDA2025-06-09
allergy nasalANDA2024-11-22
allernazeNew Drug Application2010-11-23
basic care nasal allergyANDA2022-10-13
blt-25 kitunapproved drug other2024-09-11
bupivilog kitunapproved drug other2024-12-31
bupivilog procedure kitNew Drug Application2014-01-30
calcipotriene 0.005% / triamcinolone acetonide 0.1%unapproved drug other2019-05-10
careone allergy reliefANDA2023-10-23
cortaren corticosteroid/anti-inflammatory systemANDA2022-02-24
Show 70 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
atopic dermatitisEFO_0000274D003876L20
ulcerative colitisEFO_0000729D003093K51
ankylosing spondylitisEFO_0003898D013167M45
nephrotic syndromeEFO_0004255D009404N04
multiple sclerosisEFO_0003885D009103G35
uveitisEFO_1001231D014605H20.9
inflammationMP_0001845D007249—
pulmonary tuberculosisEFO_1000049D014397A15
adrenal insufficiency—D000309—
systemic lupus erythematosusEFO_0002690D008180M32
Show 26 more
Agency Specific
FDA
EMA
Expiration
Code
TRIAMCINOLONE ACETONIDE, XIPERE, BAUSCH AND LOMB INC
2024-10-22NP
Patent Expiration
Patent
Expires
Flag
FDA Information
Triamcinolone Acetonide, Xipere, Bausch And Lomb Inc
99370752034-05-02DP
96363322033-11-08U-3234
86367132027-05-02U-3234
Triamcinolone Acetonide, Zilretta, Pacira Pharms Inc
88284402031-08-04DP
95550482031-08-04U-2151
Triamcinolone Acetonide, Triesence, Harrow Eye
81289602029-12-17DP
82118802029-03-10U-1257, U-1258
ATC Codes
A: Alimentary tract and metabolism drugs
— A01: Stomatological preparations
— A01A: Stomatological preparations
— A01AC: Corticosteroids for local oral treatment
— A01AC01: Triamcinolone
C: Cardiovascular system drugs
— C05: Vasoprotectives
— C05A: Agents for treatment of hemorrhoids and anal fissures for topical use
— C05AA: Corticosteroids, topical for treatment of hemorrhoids and anal fissures
— C05AA12: Triamcinolone
D: Dermatologicals
— D07: Corticosteroids, dermatological preparations
— D07A: Corticosteroid dermatological preparations, plain
— D07AB: Corticosteroids, moderately potent (group ii)
— D07AB09: Triamcinolone
— D07B: Corticosteroids, combinations with antiseptics
— D07BB: Corticosteroids, moderately potent, combinations with antiseptics
— D07BB03: Triamcinolone and antiseptics
— D07C: Corticosteroids, combinations with antibiotics
— D07CB: Corticosteroids, moderately potent, combinations with antibiotics
— D07CB01: Triamcinolone and antibiotics
— D07X: Corticosteroids, other combinations
— D07XB: Corticosteroids, moderately potent, other combinations
— D07XB02: Triamcinolone
H: Systemic hormonal preparations, excl. sex hormones and insulins
— H02: Corticosteroids for systemic use
— H02A: Corticosteroids for systemic use, plain
— H02AB: Glucocorticoids, systemic
— H02AB08: Triamcinolone
R: Respiratory system drugs
— R01: Nasal preparations
— R01A: Decongestants and other nasal preparations for topical use
— R01AD: Corticosteroid nasal preparations for topical use
— R01AD11: Triamcinolone
— R03: Drugs for obstructive airway diseases
— R03B: Other drugs for obstructive airway diseases, inhalants in atc
— R03BA: Glucocorticoid inhalants for obstructive airway disease
— R03BA06: Triamcinolone
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01B: Antiinflammatory agents, ophthalmologic
— S01BA: Corticosteroid ophthalmologic antiinflammatory agents, plain
— S01BA05: Triamcinolone
— S02: Otologicals
— S02C: Corticosteroids and antiinfectives in combination, otologic
— S02CA: Corticosteroids and antiinfectives in combination
— S02CA04: Triamcinolone and antiinfectives
HCPCS
Code
Description
J3299
Injection, triamcinolone acetonide (xipere), 1 mg
J3300
Injection, triamcinolone acetonide, preservative free, 1 mg
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
J3302
Injection, triamcinolone diacetate, per 5 mg
J3303
Injection, triamcinolone hexacetonide, per 5 mg
J3304
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
J7683
Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
J7684
Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Clinical
Clinical Trials
1054 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ObesityD009765EFO_0001073E66.9———1—1
AdiposityD050154—————1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Macular edemaD008269————4——4
Diabetic retinopathyD003930EFO_0003770———2——2
EdemaD004487—R60.9——2——2
Retinal vein occlusionD012170EFO_1001157H34.81——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Magnetic resonance imagingD008279———1———1
OsteoarthritisD010003EFO_0002506M15-M19—1———1
TherapeuticsD013812———1———1
Joint diseasesD007592—M12.9—1———1
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTriamcinolone
INNtriamcinolone
Description
Triamcinolone is a C21-steroid hormone that is 1,4-pregnadiene-3,20-dione carrying four hydroxy substituents at positions 11beta, 16alpha, 17alpha and 21 as well as a fluoro substituent at position 9. Used in the form of its 16,17-acetonide to treat various skin infections. It has a role as an anti-allergic agent and an anti-inflammatory drug. It is a fluorinated steroid, an 11beta-hydroxy steroid, a 20-oxo steroid, a 21-hydroxy steroid, a 3-oxo-Delta(4) steroid, a glucocorticoid, a 17alpha-hydroxy steroid, a 16alpha-hydroxy steroid, a C21-steroid hormone, a primary alpha-hydroxy ketone and a tertiary alpha-hydroxy ketone. It derives from a hydride of a pregnane.
Classification
Small molecule
Drug classsteroids (not prednisolone derivatives)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
Identifiers
PDB—
CAS-ID124-94-7
RxCUI—
ChEMBL IDCHEMBL1451
ChEBI ID9667
PubChem CID31307
DrugBankDB00620
UNII ID1ZK20VI6TY (ChemIDplus, GSRS)
Target
Agency Approved
NR3C1
NR3C1
Organism
Homo sapiens
Gene name
NR3C1
Gene synonyms
GRL
NCBI Gene ID
2908
Protein name
glucocorticoid receptor
Protein synonyms
Nuclear receptor subfamily 3 group C member 1, nuclear receptor subfamily 3 group C member 1 variant hGR-B(54), nuclear receptor subfamily 3 group C member 1 variant hGR-B(77), nuclear receptor subfamily 3 group C member 1 variant hGR-B(93), nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
Uniprot ID
Q6N0A4
Mouse ortholog
Nr3c1 (14815)
glucocorticoid receptor (Q61629)
Alternate
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Zilretta – Pacira BioSciences
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Zilretta – Flexion Therapeutics
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Triamcinolone
+
Nystatin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Triamcinolone
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 25,855 documents
View more details
Safety
Black-box Warning
Black-box warning for: Blt-25 kit, Bupivilog kit, Mlk f1 kit, Mlk f3 kit, Mlk f4 kit, Mlk kit f2
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
27,289 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use